Morning Briefing
Summaries of health policy coverage from major news organizations
Infectious-Disease Expert Jeanne Marrazzo To Succeed Fauci At NIH
Jeanne M. Marrazzo, a University of Alabama at Birmingham infectious-disease expert, will succeed Anthony S. Fauci this fall as director of the National Institute of Allergy and Infectious Diseases, federal officials announced Wednesday. The $6.3 billion research institute is among the largest of the 27 institutes and centers that constitute the National Institutes of Health, America鈥檚 flagship biomedical agency. NIAID is also particularly prominent given its involvement in the response to the coronavirus pandemic and other diseases; it has also received attention because of Fauci鈥檚 own high profile and Republicans鈥 ongoing efforts to investigate the institute鈥檚 workings. (Diamond and Roubein, 8/2)
Marrazzo鈥檚 research has focused on sexually transmitted diseases and the prevention of HIV infection. At the university, she is director of the medical school鈥檚 division of infectious diseases. Her appointment was made by Lawrence Tabak, acting director for the National Institutes of Health. (8/2)
The announcement comes roughly eight months after longtime institute director Anthony Fauci stepped down. ... Marrazzo is 鈥渧ery well-liked, very respected鈥 and experienced, Fauci told STAT. 鈥淪he鈥檚 going to be a good fit. It鈥檚 a great challenge that she鈥檚 going to be facing; it鈥檚 going to be exciting for her.鈥 (Owermohle, 8/2)
Her selection is drawing praise from researchers and AIDS activists. The Infectious Diseases Society of America cited her 鈥渋nnumerable qualifications,鈥 including her mentorship of new infectious disease specialists at UAB. Marrazzo will also be the first openly gay director of an NIH institute. 鈥淚 couldn鈥檛 be happier. She鈥檚 somebody who gets the big picture,鈥 says University of California, San Diego, epidemiologist Steffanie Strathdee, who got to know Marrazzo through the international HIV Prevention Trials Network. She added that Marrazzo 鈥渋s superdedicated to patients鈥 including those from vulnerable groups, such as lesbian and bisexual women. 鈥淕iven NIH鈥檚 history, we need someone who really understands diversity and inclusion,鈥 Strathdee says. (J. Kaiser, 8/2)